Published in J Immunol on August 01, 1980
T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci U S A (1981) 2.51
Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J Exp Med (1981) 2.46
Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes. Proc Natl Acad Sci U S A (1984) 2.17
Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest (1984) 2.00
Identification of a specific interleukin 1 inhibitor in the urine of febrile patients. J Exp Med (1984) 1.90
Effect of interleukin 1 on human thymocytes and purified human T cells. J Exp Med (1981) 1.50
Stimulation of human gamma interferon production by diterpene esters. Infect Immun (1981) 1.45
Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J Exp Med (1986) 1.40
Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest (1982) 1.33
Specific receptors for phorbol esters in lymphoid cell populations: role in enhanced production of T-cell growth factor. Proc Natl Acad Sci U S A (1981) 1.24
Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes. Immunology (1989) 1.15
An antigen receptor-driven, interleukin 2-independent pathway for proliferation of murine cytolytic T lymphocyte clones. J Exp Med (1986) 1.12
Influence of age on the production and regulation of interleukin-1 in mice. Immunology (1985) 1.11
Analysis of T cell activation with a non-mitogenic anti CD3 antibody and the phorbol ester TPA. Clin Exp Immunol (1985) 1.05
Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation. Mol Cell Biol (1990) 1.01
Helper cells in the autologous mixed lymphocyte reaction. III. Production of helper factor(s) distinct from interleukin 2. J Exp Med (1982) 0.90
Immunoregulatory circuits in the acquired immune deficiency syndrome and related complex. Production of and response to interleukins 1 and 2, NK function and its enhancement by interleukin-2 and kinetics of the autologous mixed lymphocyte reaction. Clin Exp Immunol (1985) 0.89
TPA (12-O-tetradecanoyl-phorbol-13-acetate) activation and differentiation of human peripheral B lymphocytes. Immunology (1984) 0.89
Macrophage-derived growth factor for osteoblast-like cells and chondrocytes. Proc Natl Acad Sci U S A (1984) 0.88
Interleukin 2 is mitogenic for nu/nu and nu/+ murine spleen cells. Proc Natl Acad Sci U S A (1981) 0.85
Activation and fusion induced by 1 alpha,25-dihydroxyvitamin D3 and their relation in alveolar macrophages. Proc Natl Acad Sci U S A (1984) 0.84
Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A (1984) 0.84
Deficiency in suppressor T cell activity in aged animals. Reconstitution of this activity by interleukin 2. J Exp Med (1983) 0.83
Phylogeny of interleukins: growth factors produced by leucocytes of the cyprinid fish, Cyprinus carpio L. Immunology (1984) 0.82
In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosis. Clin Exp Immunol (1985) 0.80
Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells. Immunology (1984) 0.79
Induction of human T-lymphocyte colonies by phorbol myristate acetate. Immunology (1983) 0.79
LPF-induced T cell colony formation: effect of PMA and interleukin-2, and surface marker analysis. Clin Exp Immunol (1985) 0.77
Proliferation in vitro of Lyt2-,L3T4- thymocytes shows responsiveness to interleukin 1. Clin Exp Immunol (1988) 0.76
Further study on the humoral response of a highly-purified spleen-derived immunosuppressive peptide (SDIP). Immunology (1981) 0.75
Xenogeneic antiserum to soluble products from activated lymphoid cells inhibits interleukin 1-mediated functions in the helper pathway of cytolytic-effector-cell differentiation. Proc Natl Acad Sci U S A (1985) 0.75
Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature (1985) 9.81
Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol (1982) 6.05
Thymoma production of T cell growth factor (Interleukin 2). J Immunol (1980) 5.58
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes. J Immunol (1978) 5.36
Interleukin 1 and T cell activation. Immunol Rev (1982) 5.00
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89
The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev (1982) 4.43
Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health (2004) 4.35
Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol (1981) 4.04
In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol (1989) 3.87
Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet (2002) 3.65
Absolute macrophage dependency of T lymphocyte activation by mitogens. J Immunol (1976) 3.61
Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A (1985) 3.39
Purification to apparent homogeneity of murine interleukin 1. J Immunol (1981) 3.33
Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science (1984) 3.17
Interaction of drugs with microtubule proteins. Fed Proc (1974) 3.14
Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med (1985) 2.84
Nucleoside transport in mammalian cells. Inhibition by colchicine. Biochemistry (1972) 2.70
The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol (1981) 2.60
CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer (2008) 2.58
T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci U S A (1981) 2.51
How does interleukin 1 activate cells? Cyclic AMP and interleukin 1 signal transduction. Immunol Today (1990) 2.48
Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses. J Immunol (1978) 2.28
Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein. Mol Cell Biol (1989) 2.28
Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1). Mol Immunol (1980) 2.28
Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate. J Immunol (1979) 2.27
In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse. J Clin Invest (1986) 2.22
Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells. J Immunol (1986) 2.14
Inhibition of the transport of several hexoses in mammalian cells by cytochalasin B. J Biol Chem (1972) 2.05
Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors. J Immunol (1980) 2.04
Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci U S A (1989) 2.02
A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother (2000) 1.99
Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis (1999) 1.96
Interleukin-2 stimulates association of protein kinase C with plasma membrane. Nature (1985) 1.96
The participation of macrophages and macrophage cell lines in the activation of T lymphocytes by mitogens. Immunol Rev (1978) 1.94
Studies on the role of lymphocyte-activating factor (Interleukin 1) in antigen-induced lymph node lymphocyte proliferation. Cell Immunol (1980) 1.92
Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS. J Immunol (1978) 1.92
Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines. J Immunol (1981) 1.88
Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J Immunol (1986) 1.87
Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1. J Immunol (1985) 1.86
Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes. J Immunol (1988) 1.86
Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res (2000) 1.86
Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D. Cell Immunol (1978) 1.86
Quinolone-resistant Salmonella typhi in Vietnam. Lancet (1998) 1.84
Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J Biol Chem (2000) 1.82
Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. Lancet (2006) 1.81
Establishment of continuous cultures of thy1.2+, Lyt1+, 2-T cells with purified interleukin 3. Cell (1981) 1.80
Physicochemical characterization of lymphocyte-activating factor (LAF). J Immunol (1979) 1.76
Serology of typhoid fever in an area of endemicity and its relevance to diagnosis. J Clin Microbiol (2001) 1.75
Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens. J Exp Med (1979) 1.73
Biochemical and physicochemical characterization of mouse B cell growth factor: a lymphokine distinct from interleukin 2. J Immunol (1983) 1.73
Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line. Infect Immun (1998) 1.72
Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. J Immunol (1980) 1.72
High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation. Infect Immun (2000) 1.70
Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation. J Exp Med (1983) 1.69
Regulation of class III major histocompatibility complex gene products by interleukin-1. Science (1986) 1.65
Biologic properties of chromatographically separated murine thymoma-derived Interleukin 2 and colony-stimulating factor. J Immunol (1981) 1.65
A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun (2007) 1.57
Preparation of goat antibodies against interleukin 1: use of an immunoadsorbent to purify interleukin 1. J Immunol (1983) 1.57
Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest (1991) 1.54
Phorbol myristic acetate enhances the production of interleukin 2. Cell Immunol (1981) 1.54
The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol (1991) 1.51
Endotoxin-induced T lymphocyte proliferation. J Immunol (1983) 1.51
Value of a single-tube widal test in diagnosis of typhoid fever in Vietnam. J Clin Microbiol (1999) 1.51
Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR. Int J Tuberc Lung Dis (2008) 1.51
The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts. J Immunol (1987) 1.49
Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology (1984) 1.49
Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem (1994) 1.46
The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol (1983) 1.46
Cyclic AMP--an intracellular second messenger for interleukin 1. Proc Natl Acad Sci U S A (1988) 1.45
Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors. Cell Immunol (1979) 1.44
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivity. Proc Natl Acad Sci U S A (1986) 1.43
"Can't you use another vaccine?" Postrabies vaccination encephalitis. J Neurol Neurosurg Psychiatry (1999) 1.42
Lymphopoietic potential of bone marrow cells from aged mice: comparison of the cellular constituents of bone marrow from young and aged mice. J Immunol (1974) 1.41
JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology (1994) 1.40
Altered cytosol/membrane enzyme redistribution on interleukin-3 activation of protein kinase C. Nature (1985) 1.39
Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF. J Immunol (1979) 1.38
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. J Immunol (1986) 1.37
Epidemic typhoid in vietnam: molecular typing of multiple-antibiotic-resistant Salmonella enterica serotype typhi from four outbreaks. J Clin Microbiol (2000) 1.36
Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation. J Biol Chem (1992) 1.35
Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in Vietnamese patients. Am J Trop Med Hyg (2001) 1.35
Activation of macrophages for microbicidal and tumoricidal effector functions by soluble factors from EL-4, a continuous T cell line. Infect Immun (1983) 1.35
HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol (1989) 1.34